Oppenheimer Downgrades Anchiano Therapeutics to Perform

Oppenheimer downgrades Anchiano Therapeutics (NASDAQ:ANCN) from Outperform to Perform.

Benzinga · 11/18/2019 13:48

Oppenheimer downgrades Anchiano Therapeutics (NASDAQ:ANCN) from Outperform to Perform.